Magnitude Biosciences is a contract research organisation and Durham University spinout, founded in 2018 and based in Durham, UK, that helps biotech, pharma and nutrition clients evaluate potential treatments using whole-organism C. elegans models. Its VivoScan platform combines automated imaging, robotics and AI to screen large compound libraries in living organisms, supporting programmes in healthy ageing, neurodegeneration, toxicity, gut health and metabolism. The company serves drug-discovery and consumer-health customers ranging from pharmaceutical companies to nutraceutical and microbiome developers.
1
Round
1
Industry
5
Tags
Sep 15, 2026
Latest raise
Funding activity · 1 round
Sep 15, 2026
GBP 1.3M
Seed
Led by Northstar Ventures
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
